OpenVoice is a cutting-edge voice cloning technology developed by a team of researchers and engineers from prestigious institutions, including MIT and Tsinghua University, in collaboration with MyShell. It stands out for its accurate tone color cloning, flexible voice style control, and groundbreaking zero-shot cross-lingual voice cloning capabilities, enabling the generation of highly nuanced and expressive speech in multiple languages and accents without requiring the language to be present in its training dataset. Integrated into the myshell.ai platform since May 2023, OpenVoice has powered millions of instant voice cloning instances, showcasing its vast potential and user acceptance. With its current non-commercial license poised to transition to allow free commercial use, OpenVoice is committed to ethical use and anti-misuse, making it a significant advancement in the realm of voice synthesis technology.